BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 8934224)

  • 1. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
    Dong JY; Fan PD; Frizzell RA
    Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
    Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
    Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.
    Grieger JC; Samulski RJ
    J Virol; 2005 Aug; 79(15):9933-44. PubMed ID: 16014954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
    Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A
    Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of genome size on AAV vector packaging.
    Wu Z; Yang H; Colosi P
    Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.
    Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF
    Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
    Wang XS; Ponnazhagan S; Srivastava A
    J Virol; 1996 Mar; 70(3):1668-77. PubMed ID: 8627687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.
    Kearns WG; Afione SA; Fulmer SB; Pang MC; Erikson D; Egan M; Landrum MJ; Flotte TR; Cutting GR
    Gene Ther; 1996 Sep; 3(9):748-55. PubMed ID: 8875221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.
    Tamayose K; Hirai Y; Shimada T
    Hum Gene Ther; 1996 Mar; 7(4):507-13. PubMed ID: 8800745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
    Yan Z; Zak R; Zhang Y; Engelhardt JF
    J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes.
    Zhang L; Wang D; Fischer H; Fan PD; Widdicombe JH; Kan YW; Dong JY
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10158-63. PubMed ID: 9707617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
    Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
    Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro packaging of adeno-associated virus DNA.
    Zhou X; Muzyczka N
    J Virol; 1998 Apr; 72(4):3241-7. PubMed ID: 9525651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
    Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
    Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.